BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1105 related articles for article (PubMed ID: 14625221)

  • 21. Evaluation of early cerebral metabolic, perfusion and microstructural changes in HCV-positive patients: a pilot study.
    Bladowska J; Zimny A; Knysz B; Małyszczak K; Kołtowska A; Szewczyk P; Gąsiorowski J; Furdal M; Sąsiadek MJ
    J Hepatol; 2013 Oct; 59(4):651-7. PubMed ID: 23680314
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metabolic mapping of gliomas using hybrid MR-PET imaging: feasibility of the method and spatial distribution of metabolic changes.
    Bisdas S; Ritz R; Bender B; Braun C; Pfannenberg C; Reimold M; Naegele T; Ernemann U
    Invest Radiol; 2013 May; 48(5):295-301. PubMed ID: 23296081
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cho/Cr ratio at MR spectroscopy as a biomarker for cellular proliferation activity and prognosis in glioma: correlation with the expression of minichromosome maintenance protein 2.
    Gao W; Wang X; Li F; Shi W; Li H; Zeng Q
    Acta Radiol; 2019 Jan; 60(1):106-112. PubMed ID: 29665708
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differentiation of primary central nervous system lymphomas from high-grade gliomas by rCBV and percentage of signal intensity recovery derived from dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging.
    Xing Z; You RX; Li J; Liu Y; Cao DR
    Clin Neuroradiol; 2014 Dec; 24(4):329-36. PubMed ID: 23994941
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multimodal metabolic imaging of cerebral gliomas: positron emission tomography with [18F]fluoroethyl-L-tyrosine and magnetic resonance spectroscopy.
    Floeth FW; Pauleit D; Wittsack HJ; Langen KJ; Reifenberger G; Hamacher K; Messing-Jünger M; Zilles K; Weber F; Stummer W; Steiger HJ; Woebker G; Müller HW; Coenen H; Sabel M
    J Neurosurg; 2005 Feb; 102(2):318-27. PubMed ID: 15739561
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnostic value of proton magnetic resonance spectroscopy in the noninvasive grading of solid gliomas: comparison of maximum and mean choline values.
    Senft C; Hattingen E; Pilatus U; Franz K; Schänzer A; Lanfermann H; Seifert V; Gasser T
    Neurosurgery; 2009 Nov; 65(5):908-13; discussion 913. PubMed ID: 19834403
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnostic performance of MRI perfusion and spectroscopy for brainstem glioma grading.
    Tran D; Nguyen DH; Nguyen HK; Nguyen-Thanh VA; Dong-Van H; Nguyen MD
    Eur Rev Med Pharmacol Sci; 2022 Nov; 26(21):7938-7948. PubMed ID: 36394742
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recognition of anaplastic foci within low-grade gliomas using MR spectroscopy.
    Bradac O; Vrana J; Jiru F; Kramar F; Netuka D; Hrabal P; Horinek D; de Lacy P; Benes V
    Br J Neurosurg; 2014 Oct; 28(5):631-6. PubMed ID: 24377726
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Monovoxel 1H magnetic resonance spectroscopy in the progression of gliomas.
    Alimenti A; Delavelle J; Lazeyras F; Yilmaz H; Dietrich PY; de Tribolet N; Lövblad KO
    Eur Neurol; 2007; 58(4):198-209. PubMed ID: 17823533
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Distinction between high-grade gliomas and solitary metastases using peritumoral 3-T magnetic resonance spectroscopy, diffusion, and perfusion imagings.
    Chiang IC; Kuo YT; Lu CY; Yeung KW; Lin WC; Sheu FO; Liu GC
    Neuroradiology; 2004 Aug; 46(8):619-27. PubMed ID: 15243726
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantitative assessment of gliomas by proton magnetic resonance spectroscopy.
    Oshiro S; Tsugu H; Komatsu F; Abe H; Onishi H; Ohmura T; Iwaasa M; Sakamoto S; Fukushima T
    Anticancer Res; 2007; 27(6A):3757-63. PubMed ID: 17970039
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Heterogeneity in malignant gliomas: a magnetic resonance analysis of spatial distribution of metabolite changes and regional blood volume.
    Wagner M; Nafe R; Jurcoane A; Pilatus U; Franz K; Rieger J; Steinbach JP; Hattingen E
    J Neurooncol; 2011 Jul; 103(3):663-72. PubMed ID: 21061143
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differentiation of intracranial tuberculomas and high grade gliomas using proton MR spectroscopy and diffusion MR imaging.
    Peng J; Ouyang Y; Fang WD; Luo TY; Li YM; Lv FJ; Zhang ZW; Li XY
    Eur J Radiol; 2012 Dec; 81(12):4057-63. PubMed ID: 22749802
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MR spectroscopy using normalized and non-normalized metabolite ratios for differentiating recurrent brain tumor from radiation injury.
    Elias AE; Carlos RC; Smith EA; Frechtling D; George B; Maly P; Sundgren PC
    Acad Radiol; 2011 Sep; 18(9):1101-8. PubMed ID: 21820634
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low-grade glioma: correlation of short echo time 1H-MR spectroscopy with 23Na MR imaging.
    Bartha R; Megyesi JF; Watling CJ
    AJNR Am J Neuroradiol; 2008 Mar; 29(3):464-70. PubMed ID: 18238848
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Distinction between recurrent glioma and radiation injury using magnetic resonance spectroscopy in combination with diffusion-weighted imaging.
    Zeng QS; Li CF; Liu H; Zhen JH; Feng DC
    Int J Radiat Oncol Biol Phys; 2007 May; 68(1):151-8. PubMed ID: 17289287
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low-grade gliomas and focal cortical developmental malformations: differentiation with proton MR spectroscopy.
    Vuori K; Kankaanranta L; Häkkinen AM; Gaily E; Valanne L; Granström ML; Joensuu H; Blomstedt G; Paetau A; Lundbom N
    Radiology; 2004 Mar; 230(3):703-8. PubMed ID: 14739313
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Noninvasive evaluation of cerebral glioma grade by using diffusion-weighted imaging-guided single-voxel proton magnetic resonance spectroscopy.
    Liu ZL; Zhou Q; Zeng QS; Li CF; Zhang K
    J Int Med Res; 2012; 40(1):76-84. PubMed ID: 22429347
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolism and regional cerebral blood volume in autoimmune inflammatory demyelinating lesions mimicking malignant gliomas.
    Blasel S; Pfeilschifter W; Jansen V; Mueller K; Zanella F; Hattingen E
    J Neurol; 2011 Jan; 258(1):113-22. PubMed ID: 20803026
    [TBL] [Abstract][Full Text] [Related]  

  • 40. White matter NAA/Cho and Cho/Cr ratios at MR spectroscopy are predictive of motor outcome in preterm infants.
    Kendall GS; Melbourne A; Johnson S; Price D; Bainbridge A; Gunny R; Huertas-Ceballos A; Cady EB; Ourselin S; Marlow N; Robertson NJ
    Radiology; 2014 Apr; 271(1):230-8. PubMed ID: 24475798
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 56.